Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, awETN40

Journal of the American College of Surgeons

Volumn 185, Issue 4, 1997, Pages 358-364

  Urakami, Atsushi ^a   Todo, Satoru ^a,b   Zhu, Yue ^a   Zhang, Shimin ^a   Jin, Maeng Bong ^a   Ishizaki, Naoki ^a   Shimamura, Tsuyoshi ^a   Totsuka, Eishi ^a   Subbotin, Vladimir ^a   Lee, Randall ^a   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; ENDOTHELIN 1; LACTATE DEHYDROGENASE; LIVER ENZYME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AWETN40; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID BLOOD LEVEL; CAVA VEIN; CONTROLLED STUDY; DOG; FEMALE; HEPATIC ARTERY; HIGH ENERGY PHOSPHATE; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; LIVER BLOOD FLOW; LIVER FUNCTION TEST; LIVER ISCHEMIA; MEAN ARTERIAL PRESSURE; NEUTROPHIL; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 12644302204     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(97)00025-2     Document Type: Article

References (39)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
2. Tran-Thi TA, Kawada N, and Decker K. Regulation of endothelin-1 action on the perfused rat liver. FEBS Letts 1993; 318:353-357.
3. Gandhi CR, Harvey SAK, and Olson MS. Hepatic effects of endothelin. Mechanism of [1251] endothelin-1 by liver derived cells. Arch Biochem Biophys 1993;305:38-46.
4. Serradeil-Le Gal C, Jouneaux C, Sanchez-Bueno A, et al. Endothelin action in rat liver. J Clin Invest 1991;87:133-138.
5. Sakamoto M, Ueno T, Kin M, et al. Ito cell contraction in response to endothelin-1 and substance P. Hepatology 1993;18: 978-983.
6. Mustafa SB, Gandhi CR, Harvey SAK, and Olson MS. Endothelin stimulates platelet activating factor synthesis by cultured rat Kupffer cells. Hepatology 1995;21:545-553.
7. Zhang JX, Pegoli W, and Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994;266: G624-G632.
8. Todo S, Zhu Y, Zhang S, et al. Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation 1997;63:217-223.
9. Mashige F, Imai K, and Osuga T A simple and sensitive assay of total serum bile acids. Clin Chim Acta 1976;70:79-86.
10. Hamamoto I, Takaya S, Todo S, et al. Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transplant Int 1994;7:89-95.
11. Stevens A. Enzyme histochemistry: diagnostic applications. In: Bancroft JD, and Stevens A, eds. Theory and Practice of Histologic Techniques. New York: Churchill Livingstone; 1990:401-411.
12. Xuan YT, Whorton AR, Shearer-Poor E, et al. Determination of immunoreactive endothelin in medium from cultured endothelial cells and human plasma. Biochem Biophys Res Commun 1989;164:326-332.
13. Karne S, Jayawickreme CK, and Lerner MR. Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from xenopus laevis dermal melanophores. J Biol Chem 1993; 268:19126-19133.
14. Sokolovsky M, Amber I, and Galron R. A novel subtype of endothelin receptors. J Biol Chem 1992;267:20551-20554.
15. Rocky D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 1997;25:2-5.
16. Ohlstein EH, Nambi P, and Ruffolo RR. Endothelin receptor subclassification. In: Ruffolo RR, ed. Endothelin Receptors From the Gene to the Human. New York: CRC Press; 1995:15-36.
17. Housset CN, Rockey DC, Friedman SL, and Bissell DM. Hepatic lipocytes: a major target for endothelin-1. J Hepatol 1995; 22(Suppl 2):55-60.
18. Tanikawa K. Hepatic sinusoidal cells and sinusoidal circulation. J Gastroenterol Hepatol 1995;10:S8-S11.
19. Suzuki N, Matsumoto H, Kitada C, et al. A sensitive sandwichenzyme immunoassay for human endothelin. J Immunol Methods 1989;118:245-250.
20. Watanabe T, Suzuki N, Shimamoto N, et al. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991;69:370-377.
21. Shibouta Y, Suzuki N, Shino A, et al. Pathophysiological role of endothelin in acute renal failure. Life Sci 1990;46:1611-1618.
22. Nakamura S, Nishiyama R, Serizawa A, et al. Hepatic release of endothelin-1 after warm ischemia. Transplantation 1995;59: 679-684.
23. Kawamura E, Yamanaka N, Okamoto E, et al. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology 1995;21: 1138-1143.
24. Ohuchi T, Tada K, and Akamatsu K. Endogenous ET-1 contributes to liver injury induced by galactosamine and endotoxin in isolated perfused rat liver. Am J Physiol 1995;268:G997-G1003.
25. Rakugi H, Tabuchi Y, Nakamaru M, et al. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 1990;169:973-977.
26. Yoshizumi M. Kurihara H, Morita T, et al. Interleukin increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 1990;166:324-329.
27. Housset CN, Rockey DC, and Bissell DM. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin-1. Proc Natl Acad Sci USA 1993;90:9266-9270.
28. Wagner OF, Christ G, Wojta J, et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992; 267:16066-16068.
29. Pinsky DJ, Oz MC, Koga S, et al. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest 1994;93:2291-2297.
30. Herrera FJ, Codoceo R, Cienfuegos J, et al. Bile acid profile as early indicator of allograft function during orthotopic liver transplantation. Eur Surg Res 1990;22:19-26.
31. Kamiike W, Burdelski M, Steinhoff G, et al. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 1988;45:138-143.
32. Okumura S, Takei Y, Kawano S, et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 1994;19:155-161.
33. Jaeschke H, Farhood A, and Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990;4:3355-3359.
34. McMillen MA, Huribal M, and Sumpio B. Common pathway of endothelial-leukocyte interaction in shock, ischemia, and reperfusion. Am J Surg 1993;166:557-562.
35. Ishida K, Takeshige K, and Minakami S. Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine. Biochem Biophys Res Commun 1990; 173:496-500.
36. Morita T, Kurihara H, Yoshizumi M, et al. Human polymorphonuclear leukocytes have dual effects on endothelin-1. Heart Vessels 1993;8:1-6.
37. Uprichard ACG, Chi L, and Lucchesi BR. Functional consequence of big endothelin conversion. Pharmacology 1993;47: 277-285.
38. Lopez Farre A, Riesco A, Espinosa G, et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993;88:1661-1671.
39. MacCarron RM, Wang L, Stanimirovic DB, and Spatz M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993;156: 31-34.